ArticleClinical medicine insights. Case reports2014
Switching from nitrate therapy to ranolazine in patients with coronary artery disease receiving phosphodiesterase type-5 inhibitors for erectile dysfunction.
Dioma U Udeoji et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.